An evaluation of the product containing Peria Katak (Momordica charantia)

The efficacy and safety of Momordica charantia based on relevant studies and reviews are described. M. charantia also known as bitter melon has been proposed to exert effects in lowering blood glucose levels by means of various forms and extracts from the plant. Over the years, commercially available preparations containing bitter melon are made available in the market despite limitations on available clinical trials. Clinical trial conducted demonstrates variety in findings on the effect of M. charantia on glycemic control with mostly not exhibiting statistically significant differences. Monitoring is vital in view of the reported side effects and precaution warranted for the specific individuals and unknown herbal-drug or herbal-food interaction that could possibly interrupt the overall management plan. For the meantime, findings generated from the studies only provide implication on the potential advantages that M. charantia offers in preventing and managing type 2 diabetes as well as the microvascular complications instead of a certain conclusion.